New drug shows promise for rare stomach disorder
NCT ID NCT03678545
First seen Nov 05, 2025 · Last updated Apr 30, 2026 · Updated 24 times
Summary
This study tested a drug called dupilumab in 41 people aged 12 to 70 with eosinophilic gastritis, a condition where too many immune cells cause stomach inflammation. Participants received either dupilumab or a placebo injection every two weeks for 12 weeks, with an option to continue treatment for 24 more weeks. The main goal was to see if dupilumab could reduce the number of these immune cells in the stomach lining.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EOSINOPHILIC GASTROENTERITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
Northwestern Medicine Digestive Health Center
Chicago, Illinois, 60611, United States
-
Riley Children's Hospital
Indianapolis, Indiana, 46202, United States
-
Texas Children's Hospital
Houston, Texas, 77030, United States
-
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
Tufts Medical Center
Boston, Massachusetts, 02111, United States
-
University of Colorado Denver and Hospital
Aurora, Colorado, 80045, United States
-
University of North Carolina School of Medicine
Chapel Hill, North Carolina, 27599, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
University of Utah Hospital
Salt Lake City, Utah, 84132, United States
Conditions
Explore the condition pages connected to this study.